r.nilsen
Submits third-party assay reports on material purchased directly. Based in Odense.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
99.11%
n=5
Suppliers covered
4
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043433 | Semaglutide | WXT | WXT-2602-G4442 | Janoshik | 2026-Q2 | 97.93 | 4.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019606 | TB-500 | Homopeptide | HOMO-2507-L1962 | VendorInvestigate | 2025-Q4 | 99.42 | 5.05 | 102.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019445 | GHRP-2 | Homopeptide | HOMO-2505-T8504 | VendorInvestigate | 2025-Q4 | 99.13 | 4.80 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020978 | MK-677 (Ibutamoren mesylate) | CPC | CPC-2503-G3418 | VendorInvestigate | 2025-Q2 | 97.70 | 5.20 | 95.9 | Buyer-sourced | 1 | FAIL |
| AX-2025-020457 | Liraglutide | KP | KP-2502-E5076 | Janoshik | 2025-Q1 | 99.11 | 6.98 | 98.5 | Supplier-supplied | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| Homopeptide | 2 | n<3 |
| WXT | 1 | n<3 |
| CPC | 1 | n<3 |
| KP | 1 | n<3 |